Literature DB >> 21385566

Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.

Taisuke Kinoshita1, Go Nagamatsu, Takeo Kosaka, Keiyo Takubo, Akitsu Hotta, James Ellis, Toshio Suda.   

Abstract

During cell division, one of the major features of somatic cell reprogramming by defined factors, cells are potentially exposed to DNA damage. Inactivation of the tumor suppressor gene p53 raised reprogramming efficiency but resulted in an increased number of abnormal chromosomes in established iPS cells. Ataxia-telangiectasia mutated (ATM), which is critical in the cellular response to DNA double-strand breaks, may also play an important role during reprogramming. To clarify the function of ATM in somatic cell reprogramming, we investigated reprogramming in ATM-deficient (ATM-KO) tail-tip fibroblasts (TTFs). Although reprogramming efficiency was greatly reduced in ATM-KO TTFs, ATM-KO iPS cells were successfully generated and showed the same proliferation activity as WT iPS cells. ATM-KO iPS cells had a gene expression profile similar to ES cells and WT iPS cells, and had the capacity to differentiate into all three germ layers. On the other hand, ATM-KO iPS cells accumulated abnormal genome structures upon continuous passages. Even with the abnormal karyotype, ATM-KO iPS cells retained pluripotent cell characteristics for at least 20 passages. These data indicate that ATM does participate in the reprogramming process, although its role is not essential.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385566     DOI: 10.1016/j.bbrc.2011.03.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.

Authors:  Peiyee Lee; Nathan T Martin; Kotoka Nakamura; Soheila Azghadi; Mandana Amiri; Uri Ben-David; Susan Perlman; Richard A Gatti; Hailiang Hu; William E Lowry
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Genetic instability of modified stem cells - a first step towards malignant transformation?

Authors:  Doris Steinemann; Gudrun Göhring; Brigitte Schlegelberger
Journal:  Am J Stem Cells       Date:  2013-03-08

3.  Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.

Authors:  Junjie Lu; Hu Li; Anna Baccei; Takayo Sasaki; David M Gilbert; Paul H Lerou
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

4.  Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.

Authors:  Loïc Garçon; Jingping Ge; Shwetha H Manjunath; Jason A Mills; Marisa Apicella; Shefali Parikh; Lisa M Sullivan; Gregory M Podsakoff; Paul Gadue; Deborah L French; Philip J Mason; Monica Bessler; Mitchell J Weiss
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

Review 5.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

6.  Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.

Authors:  Guangbin Xia; Katherine Santostefano; Takashi Hamazaki; Jilin Liu; S H Subramony; Naohiro Terada; Tetsuo Ashizawa
Journal:  J Mol Neurosci       Date:  2012-12-09       Impact factor: 3.444

Review 7.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

8.  Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming.

Authors:  Taisuke Kinoshita; Go Nagamatsu; Shigeru Saito; Keiyo Takubo; Katsuhisa Horimoto; Toshio Suda
Journal:  J Biol Chem       Date:  2014-04-14       Impact factor: 5.157

9.  Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype.

Authors:  Sam Nayler; Magtouf Gatei; Sergei Kozlov; Richard Gatti; Jessica C Mar; Christine A Wells; Martin Lavin; Ernst Wolvetang
Journal:  Stem Cells Transl Med       Date:  2012-06-28       Impact factor: 6.940

10.  Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells.

Authors:  Kerstin Felgentreff; Likun Du; Katja G Weinacht; Kerry Dobbs; Margarita Bartish; Silvia Giliani; Thorsten Schlaeger; Alexander DeVine; Axel Schambach; Lisa J Woodbine; Graham Davies; Sachin N Baxi; Mirjam van der Burg; Jack Bleesing; Andrew Gennery; John Manis; Qiang Pan-Hammarström; Luigi D Notarangelo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.